EU regulator backs GSK’s bone marrow cancer therapy – Reuters
… had recommended approving its oral therapy to treat anaemia in patients with a type of bone marrow cancer called myelofibrosis.
… had recommended approving its oral therapy to treat anaemia in patients with a type of bone marrow cancer called myelofibrosis.